SG11201501146VA - Improved methods for treating cancer with reduced renal toxicity - Google Patents

Improved methods for treating cancer with reduced renal toxicity

Info

Publication number: SG11201501146VA
Authority: SG; Singapore
Prior art keywords: treating cancer; improved methods; renal toxicity; reduced renal; toxicity
Prior art date: 2012-08-13

Application number

SG11201501146VA

Inventor

Teni Boulikas

George Stathopoulos

Original Assignee

Teni Boulikas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-08-13

Filing date

2012-08-13

Publication date

2015-05-28

2012-08-13 Application filed by Teni Boulikas filed Critical Teni Boulikas

2015-05-28 Publication of SG11201501146VA publication Critical patent/SG11201501146VA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SG11201501146VA 2012-08-13 2012-08-13 Improved methods for treating cancer with reduced renal toxicity SG11201501146VA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2012/050630 WO2014027996A1 (en)	2012-08-13	2012-08-13	Improved methods for treating cancer with reduced renal toxicity

Publications (1)

Publication Number	Publication Date
SG11201501146VA true SG11201501146VA (en)	2015-05-28

Family

ID=50101360

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201501146VA SG11201501146VA (en)	2012-08-13	2012-08-13	Improved methods for treating cancer with reduced renal toxicity

Country Status (13)

Country	Link
US (1)	US20150258140A1 (en)
EP (1)	EP2882420A4 (en)
JP (1)	JP2015528446A (en)
CN (1)	CN104736143A (en)
AU (1)	AU2012387681A1 (en)
BR (1)	BR112015003111A2 (en)
CA (1)	CA2882156A1 (en)
EA (1)	EA201590325A1 (en)
IN (1)	IN2015KN00375A (en)
MA (1)	MA37931A1 (en)
SG (1)	SG11201501146VA (en)
WO (1)	WO2014027996A1 (en)
ZA (1)	ZA201501123B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI643845B (en) *	2012-05-11	2018-12-11	重植治療公司	Carbazole-containing sulfonamides as cryptochrome modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04169531A (en) *	1990-11-01	1992-06-17	Sumitomo Pharmaceut Co Ltd	Liposome preparation containing lipo-soluble platinum complex
JPH04169532A (en) *	1990-11-01	1992-06-17	Sumitomo Pharmaceut Co Ltd	Liposome preparation containing lipo-soluble platinum complex
EP0551169A1 (en) *	1992-01-10	1993-07-14	Takeda Chemical Industries, Ltd.	Liposome composition and production thereof
ATE252372T1 (en) *	1996-08-23	2003-11-15	Sequus Pharm Inc	LIPOSOMES CONTAINING CISPLATIN
DE19954613A1 (en) *	1999-11-12	2001-05-17	Enthone Omi Deutschland Gmbh	Process for electroless tinning of copper or copper alloys
US7850990B2 (en) *	2001-10-03	2010-12-14	Celator Pharmaceuticals, Inc.	Compositions for delivery of drug combinations
GR20060100144A (en) *	2006-03-03	2007-10-17		Cancer treatment using oxaliplatin encapsulated into liposomes and co-encapsulation into the liposome particle of more than one pharmaceutical preparations, or genes
EP2123258A1 (en) *	2008-05-23	2009-11-25	Liplasome Pharma A/S	Liposomes for drug delivery
WO2010148163A1 (en) *	2009-06-18	2010-12-23	University Of Utah Research Foundation	Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy

2012
- 2012-08-12 MA MA37931A patent/MA37931A1/en unknown
- 2012-08-13 WO PCT/US2012/050630 patent/WO2014027996A1/en active Application Filing
- 2012-08-13 EP EP12883054.4A patent/EP2882420A4/en not_active Withdrawn
- 2012-08-13 JP JP2015527429A patent/JP2015528446A/en active Pending
- 2012-08-13 SG SG11201501146VA patent/SG11201501146VA/en unknown
- 2012-08-13 BR BR112015003111A patent/BR112015003111A2/en not_active IP Right Cessation
- 2012-08-13 IN IN375KON2015 patent/IN2015KN00375A/en unknown
- 2012-08-13 CN CN201280075225.2A patent/CN104736143A/en active Pending
- 2012-08-13 AU AU2012387681A patent/AU2012387681A1/en not_active Abandoned
- 2012-08-13 US US14/421,392 patent/US20150258140A1/en not_active Abandoned
- 2012-08-13 CA CA2882156A patent/CA2882156A1/en not_active Abandoned
- 2012-08-13 EA EA201590325A patent/EA201590325A1/en unknown
2015
- 2015-02-18 ZA ZA2015/01123A patent/ZA201501123B/en unknown

Also Published As

Publication number	Publication date
IN2015KN00375A (en)	2015-07-10
EA201590325A1 (en)	2015-09-30
MA37931A1 (en)	2016-07-29
ZA201501123B (en)	2020-02-26
CN104736143A (en)	2015-06-24
EP2882420A1 (en)	2015-06-17
JP2015528446A (en)	2015-09-28
EP2882420A4 (en)	2016-06-01
US20150258140A1 (en)	2015-09-17
WO2014027996A1 (en)	2014-02-20
AU2012387681A1 (en)	2015-03-05
BR112015003111A2 (en)	2017-10-10
CA2882156A1 (en)	2014-02-20

Publication	Publication Date	Title
IL267242B (en)	2020-08-31	Cancer treatment
HK1206982A1 (en)	2016-01-22	Radio-pharmaceutical complexes
HK1220155A1 (en)	2017-04-28	Methods for treating cancer
EP2635286A4 (en)	2014-11-12	Methods for treating cancer
EP2830648A4 (en)	2015-12-02	Methods for treating neoplasia
IL228644A0 (en)	2013-12-31	Methods for treating cancer
HK1210049A1 (en)	2016-04-15	Combination therapies for treating cancer
IL254964A0 (en)	2017-12-31	Method for treating breast cancer
HK1210136A1 (en)	2016-04-15	Ingenol-derived compounds that can be used for treating cancer
HK1210023A1 (en)	2016-04-15	Cancer treatment
PT3016682T (en)	2020-05-20	Methods for treating cancer
EP2886122A4 (en)	2016-05-18	Agent for treating cancer
ZA201406172B (en)	2016-05-25	Compounds and methods for treating leukemia
ZA201504169B (en)	2020-12-23	Anti-adam28 antibody for treating cancer
HK1209040A1 (en)	2016-03-24	Methods for treating vestibulotoxicity
ZA201501123B (en)	2020-02-26	Improved methods for treating cancer with reduced renal toxicity
GB201222563D0 (en)	2013-01-30	Cancer treatment
AU2012901918A0 (en)	2012-05-31	Methods for treating cancer
GB201210358D0 (en)	2012-07-25	Complexes